Skip to content
MedsAcross

Medicine

Leucovorin 25 mg tablet

Leucovorin · Oral
Available on requestPrescription onlyUS FDAGeneric name

Leucovorin 25 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 15°C to 25°C (59°F to 77°F). Protect from light and moisture.

Key facts

Active ingredient (INN)
Leucovorin
Brand
Sold under the generic name
Strength
25 mg
Dosage form
Tablet
Route
Oral
Packs
25 tablets, 20 blister pack and 4 more
Manufacturers
American Health PackagingEpic PharmaHikma PharmaceuticalsIngenus PharmaceuticalsLeading PharmaMajor PharmaceuticalsTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 15°C to 25°C (59°F to 77°F). Protect from light and moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 June 1990
Identifiers
RxCUI 197860, 197861, 197862 +1DailyMed set ID c8102043-79f2-421a-b849-94bac19007a6, f7004cbd-9827-466e-9683-adce4f13c6a6, 33663425-4731-4977-9127-9e59b6b91497 +4NDC 69315-187, 60687-227, 0054-4499 +4Application ANDA213929, ANDA071199, ANDA072736 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
25 tablet in 1 bottle42806-359-25Epic Pharma16 April 2020
25 tablet in 1 bottle0054-4499-11Hikma Pharmaceuticals22 March 1993
25 tablet in 1 bottle50742-184-25Ingenus Pharmaceuticals30 July 2020
25 tablet in 1 bottle69315-187-25Leading Pharma16 November 2020
25 tablet in 1 bottle0555-0485-27Teva Pharmaceuticals30 June 1990
20 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack60687-227-94American Health Packaging17 February 2017
20 blister pack in 1 carton / 1 tablet in 1 blister pack0904-7584-10Major Pharmaceuticals27 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 June 1952Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Leucovorin

Clinical summary

Leucovorin is a folate analog indicated for rescue after high-dose methotrexate (MTX) therapy in adult and pediatric patients, among other approved uses. MedsAcross supplies Leucovorin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Leucovorin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Leucovorin 25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.